Thursday 21 Nov, 2024 05:23 PM
Site map | Locate Us | Login
   Kilburn Eng to acquire Monga Strayfield for Rs 123 cr    Natco Pharma submits ANDA with US FDA for Risdiplam    Adani Enterprises Ltd leads losers in 'A' group    Godfrey Phillips declares interim dividend of Rs 35/share    Strides Pharma jumps on securing NCLT nod for OneSource    Honasa Consumer Ltd leads losers in 'B' group    Datamatics appoints Ankush Akar as SVP & CFO    Volumes soar at Ambuja Cements Ltd counter    Honasa Consumer slumps after AICPDF flags Co's unsold inventory worth Rs 300 crore    Energy stocks edge lower    FMCG shares slide    Utilties stocks slide    BSE SME Mangal Compusolution slips on debut    NLC India rallies after board OKs to invest Rs 3,720 cr in arm, NIRL    Federal Bank Ltd gains for third consecutive session 
Saravan Stocks
       
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Stock Alert: Titan Company, Dr Reddy's Lab, Berger Paints, GAIL (India), Mankind Pharma
06-Nov-24   08:26 Hrs IST

Result Today:

Power Grid Corporation of India, Apollo Hospitals, Tata Steel, Aadhar Housing Finance, Jindal Steel & Power, Blue Star, Chambal Fertilisers, Delta Corp, Endurance Technologies, Gandhar Oil Refinery, GE Power India, Gujarat Pipavav Port, Granules India, Gujarat Gas, JB Chemicals, JK Lakshmi Cement, RITES, Sonata Software, TeamLease Services, Thangamayil Jewellery, and Trident will declare their quarterly earnings later today.

Stocks to Watch:

Titan Company reported 25% decline in standalone net profit to Rs 705 crore in Q2 FY25 as against Rs 940 crore posted in Q2 FY24. However, revenue from operations jumped 23.88% year on year (YoY) to Rs 12,268 crore in the quarter ended 30 September 2024.

Dr Reddy's Laboratories' consolidated net profit decreased 15.28% to Rs 1,255.7 crore in Q2 FY25 as against Rs 1,482.2 crore posted in Q2 FY24. Total revenue from operations stood at Rs 8,038.2 crore in Q2 FY25, up 16.45% as agasint Rs 6,902.6 crore posted in Q2 FY24. The revenue growth was primarily driven by growth in global generics revenues.

Meanwhile, the company's board approved fund infusion by way of investment in equity shares of Dr. Reddy's Laboratories LLC, Russia, a step-down wholly-owned subsidiary, upto an amount of Rs 600 crore. The fund will be used for working capital requirements.

Mankind Pharma's consolidated net profit jumped 28.96% to Rs 659 crore during the quarter as compared with Rs 511 crore in Q2 FY24. Revenue increased 13.58% YoY to Rs 3,076 crore during the quarter.

GAIL India 's consolidated net profit declined 16% to Rs 2,960 crore despite a 3.47% increase in revenue (excluding excise duty) to Rs 32,911.73 crore in Q2 FY25 over Q2 FY24..

Berger Paints India's consolidated net profit declined 7.53% to Rs 270 crore in Q2 FY25 as compared with Rs 292 crore in Q2 FY24. Revenue rose 0.28% YoY to Rs 2,775 crore during the quarter.

Timken India reported 3.22% decline in consolidated net profit to Rs 90 crore despite of 10.41% increase in revenue to Rs 753 crore in Q2 FY25 over Q2 FY24.

JK Tyre's consolidated net profit declined 43.77% to Rs 140 crore on 7.9% fall in revenue to Rs 3621 crore in Q2 FY25 over Q2 FY24.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 37007264
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd